Effects of MdmX on Mdm2-mediated downregulation of pRB

FEBS Lett. 2006 Mar 20;580(7):1753-8. doi: 10.1016/j.febslet.2006.02.029. Epub 2006 Feb 21.

Abstract

Mdm2, a RING-finger type ubiquitin ligase, is overexpressed in a variety of human cancers. It promotes ubiquitination of the tumor suppressor p53 and can function as an oncogene by largely downregulating p53. Recently, we reported that Mdm2 degrades retinoblastoma tumor suppressor protein (pRB) via the ubiquitin-proteasome system. In the present study, we assessed the effects of MdmX, a structural homolog of Mdm2, on the Mdm2-mediated ubiquitination of pRB. MdmX is known to negatively regulate p53 function by enhancing the Mdm2-mediated ubiquitination and degradation of p53. Interestingly, MdmX inhibited the Mdm2-mediated pRB ubiquitination. Furthermore, an MdmX siRNA decreased the endogenous pRB level, while MdmX overexpression stimulated pRB functions in cultured cells. Therefore, MdmX may have different roles in the regulation of Mdm2 activity for ubiquitination of pRB and p53.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Cycle Proteins
  • Cells, Cultured
  • Down-Regulation
  • Humans
  • Nuclear Proteins / physiology*
  • Proteasome Endopeptidase Complex / metabolism
  • Proto-Oncogene Proteins / physiology*
  • Proto-Oncogene Proteins c-mdm2 / physiology*
  • RNA, Small Interfering / pharmacology
  • Retinoblastoma Protein / genetics*
  • Retinoblastoma Protein / metabolism
  • Tumor Suppressor Protein p53 / metabolism
  • Ubiquitin / metabolism

Substances

  • Cell Cycle Proteins
  • MDM4 protein, human
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • RNA, Small Interfering
  • Retinoblastoma Protein
  • Tumor Suppressor Protein p53
  • Ubiquitin
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2
  • Proteasome Endopeptidase Complex